Purchases and Sales Made in Q2 2024 in Xeris Biopharma Holdings, Inc. (XERS)
This table provides information about the institutional ownership of Xeris Biopharma Holdings, Inc. (XERS) during Q2 2024. The information is specifically focused on institutions that hold shares of Xeris Biopharma Holdings, Inc..
| Report Date | Institution (Fund) | Operation | Option | Shares change | Value Range | Shares Held | Trade History |
|---|---|---|---|---|---|---|---|
|
Aug 14, 2024
Q2 2024
|
Two Sigma Investments, LP
New York, NY |
SELL
|
- |
-103K- 79.36% |
$175K - $252K
|
26.8K
$125K
|
|
|
Aug 14, 2024
Q2 2024
|
Qube Research & Technologies LTD
London, X0 |
SELL
|
- |
-155K- 86.61% |
$263K - $379K
|
23.9K
$112K
|
|
|
Aug 14, 2024
Q2 2024
|
D. E. Shaw & Co., Inc.
New York, NY |
SELL
|
- |
-189K- 26.73% |
$321K - $463K
|
518K
$2.42M
|
|
|
Aug 12, 2024
Q2 2024
|
Xtx Topco LTD
London, X0 |
SELL
|
- |
-223K- 87.54% |
$380K - $547K
|
31.8K
$149K
|
|
|
Aug 09, 2024
Q2 2024
|
Nuveen Asset Management, LLC
Chicago, IL |
SELL
|
- |
-248K- 15.59% |
$421K - $607K
|
1.34M
$6.28M
|
|
|
Jun 12, 2025
Q2 2024
|
Deutsche Bank Ag\
Frankfurt Am Main, 2M |
SELL
|
- |
-701K- 92.69% |
$1.19M - $1.72M
|
55.3K
$259K
|
|
|
Aug 14, 2024
Q2 2024
|
Ameriprise Financial Inc
Minneapolis, MN |
SELL
|
- |
-733K- 76.93% |
$1.25M - $1.8M
|
220K
$1.03M
|
|
|
May 14, 2025
Q2 2024
|
Morgan Stanley
New York, NY |
SELL
|
- |
-1.27M- 44.05% |
$2.15M - $3.11M
|
1.61M
$7.53M
|